Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia
Tiziano Barbui(University of Bergamo), Ayalew Tefferi(Mayo Clinic), Alessandra Carobbio(Ospedale Papa Giovanni XXIII), Chiara Falcone(Ospedale Papa Giovanni XXIII), Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Maria Luigia Randi(University of Padua), Heinz Gisslinger(Medical University of Vienna), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Valerio De Stefano(Agostino Gemelli University Polyclinic), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Elisa Rumi(University of Pavia), Marco Ruggeri(Ospedale San Bortolo), Guido Finazzi(Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna "Bruno Ubertini"), J. Thiele(University of Cologne), Francesco Passamonti(University of Milan), Francesco Rodeghiero(Ospedale San Bortolo), Irene Bertozzi(University of Padua)
Cited by 273
Related Papers
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k